Article in Molecules (Basel, Switzerland), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
8 authors.
Hye Jin KimCollege of Pharmacy, Integrated Research Institute of Pharmaceutical Sciences, The Catholic University of Korea, Bucheon 14662, Republic of Korea.
Lee Kyung KimCollege of Pharmacy, Integrated Research Institute of Pharmaceutical Sciences, BK21FOUR Team for Advanced Program for Smart Pharma Leaders, The Catholic University of Korea, Bucheon 14662, Republic of Korea.
Anna KimCollege of Pharmacy, Integrated Research Institute of Pharmaceutical Sciences, The Catholic University of Korea, Bucheon 14662, Republic of Korea.
Khin Myo HtwePopa Mountain National Park, Forest Department, Kyaukpadaung Township, Mandalay Division, Kyaukpadaung 05241, Myanmar.
Tae-Hwe HeoCollege of Pharmacy, Integrated Research Institute of Pharmaceutical Sciences, BK21FOUR Team for Advanced Program for Smart Pharma Leaders, The Catholic University of Korea, Bucheon 14662, Republic of Korea.
Kye Jung ShinCollege of Pharmacy, Integrated Research Institute of Pharmaceutical Sciences, The Catholic University of Korea, Bucheon 14662, Republic of Korea.
Hee Jung KimCollege of Pharmacy, Integrated Research Institute of Pharmaceutical Sciences, BK21FOUR Team for Advanced Program for Smart Pharma Leaders, The Catholic University of Korea, Bucheon 14662, Republic of Korea.ORCID 0000-0002-6122-6906
Kee Dong YoonCollege of Pharmacy, Integrated Research Institute of Pharmaceutical Sciences, The Catholic University of Korea, Bucheon 14662, Republic of Korea.
Funding
National Research Foundation of Korea NRF- 2018 R1A6A1A03025108
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.
IL-6 Inhibitory Compounds from the Aerial Parts of · full record | OpenQuestion